Ann: Appendix 3B, page-42

Take the personalities out of it.
We're these trades
1. in line with their corporate governance policy and if yes all good.
2. If not what will they do to make sure a director does not do it again?
3. Or could it have been handled much better if it were to be done again and strengthen the policy.
One key issue about governance is transparency and every Sh relies on the bod to manage it. The circumstantial evidence is a attracting attention and should not be met with silence. I know Catherine can do whatever she likes with her shares but she is also MD so with that brings the transparency and public and regulatory scrutiny unfortunately of all above board. That's why the release of her selling was made. No mention that the bod did not say and by the way we have reviewed the sale and we have found that the selling of her big parcel had been sold in a disciplined and spasmodic approach to ensure that sh's were not disadvantaged in the process and an unfair advantage was provided to others involved in the transaction!
Not hard really to confirm whether they have reviewed or not really.